Literature DB >> 18192308

Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome.

A Delluc, N Limal, X Puéchal, C Francès, J C Piette, P Cacoub.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18192308     DOI： 10.1136/ard.2006.068254

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  21 in total

Review 1.  The NLRP3 inflammasome in health and disease: the good, the bad and the ugly.

Authors:  P Menu; J E Vince
Journal:  Clin Exp Immunol       Date:  2011-07-15       Impact factor: 4.330

Review 2.  Autoinflammation: From monogenic syndromes to common skin diseases.

Authors:  Tien V Nguyen; Edward W Cowen; Kieron S Leslie
Journal:  J Am Acad Dermatol       Date:  2013-02-28       Impact factor: 11.527

Review 3.  Anti-inflammatory panacea? The expanding therapeutics of interleukin-1 blockade.

Authors:  J Michelle Kahlenberg
Journal:  Curr Opin Rheumatol       Date:  2016-05       Impact factor: 5.006

4.  [IL-1 antagonists].

Authors:  I Kötter; G Horneff
Journal:  Z Rheumatol       Date:  2010-09       Impact factor: 1.372

Review 5.  An expanding role for interleukin-1 blockade from gout to cancer.

Authors:  Charles Anthony Dinarello
Journal:  Mol Med       Date:  2014-12-16       Impact factor: 6.354

6.  Sweet's syndrome as the presenting manifestation of gall bladder adenocarcinoma.

Authors:  Rashmi Jindal; Anshu Jain; Ankur Mittal; Nadia Shirazi
Journal:  BMJ Case Rep       Date:  2012-10-12

7.  Rituximab for refractory subcutaneous Sweet's syndrome in chronic lymphocytic leukemia: A case report.

Authors:  Seyed Mehdi Hashemi; Seyed Amirhossein Fazeli; Abdolbaset Vahedi; Reza Golabchifard
Journal:  Mol Clin Oncol       Date:  2015-12-18

8.  Functional relevance of NLRP3 inflammasome-mediated interleukin (IL)-1β during acute allergic airway inflammation.

Authors:  M Ritter; K Straubinger; S Schmidt; D H Busch; S Hagner; H Garn; C Prazeres da Costa; L E Layland
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

9.  Prolonged urticaria and fever in a toddler.

Authors:  Lori Broderick; Adriana H Tremoulet; Jane C Burns; Hal M Hoffman
Journal:  Allergy Asthma Proc       Date:  2012 May-Jun       Impact factor: 2.587

Review 10.  Treating inflammation by blocking interleukin-1 in humans.

Authors:  Charles A Dinarello; Jos W M van der Meer
Journal:  Semin Immunol       Date:  2013-11-23       Impact factor: 11.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.